Neuro Event Labs has been selected in a new venture capital fund founded by leading Finnish technologists. The fund invests 500,000 Euros in the company. This complements an investment of 100,000 Euros by OmaMedical and 1.3 million Euros made by Business Finland, a Finnish national growth acceleration organization.
Tampere University Hospital (Tays), Neuro Event Labs’ key client, has been using our epilepsy monitoring solution together with a vagus nerve stimulator (VNS) to treat patients with epilepsy and to evaluate the effectiveness of the treatment. As part the cooperation, a Tays patient used NEL’s night-time epilepsy monitoring solution for a full month, right at the patient’s home.
Neuro Event Labs’ CEO Kaapo Annala pitched this week in Finland’s biggest company growth challenge, Kasvu Open. After making it to the top-10 finale (out of 839 companies), Neuro Event Labs took second place in the start-up series, as well as being voted the “audience choice” in a landslide victory.